Injectable HIV prevention drug shows promise: we worked out how much South Africa should pay for it

By Lise Jamieson, Senior Researcher, University of the Witwatersrand
Gesine Meyer-Rath, Research associate professor in Global Health, Boston University

Pre-exposure prophylaxis (PrEP) is an HIV prevention method. It is taken by people who are HIV negative, so that if they are unknowingly exposed to HIV, the drug will prevent the virus from infecting them.

The development of this method is important for South Africa because the country is the epicentre of the HIV pandemic. Around 7.5 million people in South Africa live with HIV – about a fifth of the global population of people living with HIV.

The current standard-of-care PrEP…

Read complete article

~	USA: Sanctions against UN Special Rapporteur Francesca Albanese are a disgraceful affront to international justice

~	Charges against Canadian Army members in anti-government terror plot raise alarms about right-wing extremism

~	Thirsty future: Australia’s green hydrogen targets could require vastly more water than the government hopes

~	Defence spending is like insurance – how will NZ pay the higher premiums?

~	Where do giant volcanic eruptions come from? New study finds missing link to ‘blobs’ deep within Earth

~	The Secret Lives of Mormon Wives shatters the church’s century-long effort to curate its own image

~	A weakened Iran and Hezbollah gives Lebanon an opening to chart path away from the region’s conflicts − will it be enough?

~	We interviewed 205 Australians convicted of murder and manslaughter. Alcohol’s role was alarming

~	Earth’s ‘oldest’ impact crater is much younger than previously thought – new study

~	Sound recordings can give us an animals’ eye view of the war in Ukraine